A biohybrid chiral hydrogel enhances preclinical postoperative glioblastoma therapy by multi-pronged inhibition of tumour stemness

Journal:

Nature Nanotechnology

Published:

2025-12-26

DOI:

10.1038/s41565-025-02064-2

Affiliations:

8

Authors:

12

Go to article

Institutions	Authors	Share
MOE Key Laboratory for Analytical Science of Food Safety and Biology, FZU, China	9.333333	0.78
National University of Singapore (NUS), Singapore	1.000000	0.08
The First Affiliated Hospital of Fujian Medical University, China	1.000000	0.08
National University Health System (NUHS), Singapore	0.500000	0.04
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore	0.166667	0.01

Interested in Oncology and Carcinogenesis?